Literature DB >> 24121135

Allele-specific qRT-PCR demonstrates superior detection of single nucleotide polymorphisms as genetic markers for West Nile virus compared to Luminex® and quantitative sequencing.

Gabriella Worwa1, Christy C Andrade, Tara C Thiemann, Bborie Park, Payal D Maharaj, Michael Anishchenko, Aaron C Brault, William K Reisen.   

Abstract

To enable in vivo and in vitro competitive fitness comparisons among West Nile viruses (WNV), three reference viruses were marked genetically by site-directed mutagenesis with five synonymous nucleotide substitutions in the envelope gene region of the genome. Phenotypic neutrality of the mutants was assessed experimentally by competitive replication in cell culture and genetic stability of the substituted nucleotides was confirmed by direct sequencing. Luminex(®) technology, quantitative sequencing and quantitative RT-PCR (qRT-PCR) were compared in regard to specificity, sensitivity and accuracy for quantitation of wildtype and genetically marked viruses in mixed samples based on RNA obtained from samples of known viral titers. Although Luminex(®) technology and quantitative sequencing provided semi-quantitative or qualitative measurements, a sequence-specific primer extension approach using a specific reverse primer set in singleplex qRT-PCR demonstrated the best quantitation and specificity in the detection of RNA from wildtype and mutant viruses.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fitness competition; Genetic marker; Luminex(®) technology; Quantitative sequencing; West Nile virus; qRT-PCR

Mesh:

Substances:

Year:  2013        PMID: 24121135      PMCID: PMC3856659          DOI: 10.1016/j.jviromet.2013.09.014

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  16 in total

1.  Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells.

Authors:  S C Weaver; A C Brault; W Kang; J J Holland
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Development of a high-throughput microsphere-based molecular assay to identify 15 common bloodmeal hosts of Culex mosquitoes.

Authors:  T C Thiemann; A C Brault; H B Ernest; W K Reisen
Journal:  Mol Ecol Resour       Date:  2011-12-04       Impact factor: 7.090

Review 3.  Basic concepts in RNA virus evolution.

Authors:  E Domingo; C Escarmís; N Sevilla; A Moya; S F Elena; J Quer; I S Novella; J J Holland
Journal:  FASEB J       Date:  1996-06       Impact factor: 5.191

4.  Semi-quantitative analysis of influenza samples using the Luminex xTAG(®) respiratory viral panel kit.

Authors:  Jerome Smith; Deborah Sammons; Christine Toennis; Mary Ann Butler; Francoise Blachere; Donald Beezhold
Journal:  Toxicol Mech Methods       Date:  2011-11-23       Impact factor: 2.987

5.  Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate.

Authors:  Stanley A Langevin; Richard A Bowen; Wanichaya N Ramey; Todd A Sanders; Payal D Maharaj; Ying Fang; Jennine Cornelius; Christopher M Barker; William K Reisen; David W C Beasley; Alan D T Barrett; Richard M Kinney; Claire Y-H Huang; Aaron C Brault
Journal:  J Gen Virol       Date:  2011-08-24       Impact factor: 3.891

6.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

Authors:  C M Rice; E M Lenches; S R Eddy; S J Shin; R L Sheets; J H Strauss
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

7.  A novel coding-region RNA element modulates infectious dengue virus particle production in both mammalian and mosquito cells and regulates viral replication in Aedes aegypti mosquitoes.

Authors:  Anna Maria Groat-Carmona; Susana Orozco; Peter Friebe; Anne Payne; Laura Kramer; Eva Harris
Journal:  Virology       Date:  2012-07-25       Impact factor: 3.616

8.  West Nile virus experimental evolution in vivo and the trade-off hypothesis.

Authors:  Eleanor R Deardorff; Kelly A Fitzpatrick; Greta V S Jerzak; Pei-Yong Shi; Laura D Kramer; Gregory D Ebel
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

9.  Genome sequence and attenuating mutations in West Nile virus isolate from Mexico.

Authors:  David W C Beasley; C Todd Davis; Jose Estrada-Franco; Roberto Navarro-Lopez; Arturo Campomanes-Cortes; Robert B Tesh; Scott C Weaver; Alan D T Barrett
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

10.  Differential virulence of West Nile strains for American crows.

Authors:  Aaron C Brault; Stanley A Langevin; Richard A Bowen; Nicholas A Panella; Brad J Biggerstaff; Barry R Miller; Nicholas Komar
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

View more
  4 in total

1.  Comparing competitive fitness of West Nile virus strains in avian and mosquito hosts.

Authors:  Gabriella Worwa; Sarah S Wheeler; Aaron C Brault; William K Reisen
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

2.  Comparative fitness of West Nile virus isolated during California epidemics.

Authors:  Gabriella Worwa; Andra A Hutton; Aaron C Brault; William K Reisen
Journal:  PLoS Negl Trop Dis       Date:  2019-02-04

3.  Development of a panel of three multiplex allele-specific qRT-PCR assays for quick differentiation of recombinant variants and Omicron subvariants of SARS-CoV-2.

Authors:  Jianguo Li; Zefeng Gao; Jing Chen; Ruiling Cheng; Jiahui Niu; Jialei Zhang; You Yang; Ximei Yuan; Juan Xia; Guoli Mao; Hulong Liu; Yongkang Dong; Changxin Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-08-18       Impact factor: 6.073

4.  Detection of Rare Drug Resistance Mutations by Digital PCR in a Human Influenza A Virus Model System and Clinical Samples.

Authors:  Alexandra S Whale; Claire A Bushell; Paul R Grant; Simon Cowen; Ion Gutierrez-Aguirre; Denise M O'Sullivan; Jana Žel; Mojca Milavec; Carole A Foy; Eleni Nastouli; Jeremy A Garson; Jim F Huggett
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.